Anti-Inflammatory Effects of the 35kDa Hyaluronic Acid Fragment (B-HA/HA35)

被引:11
作者
Jia, XiaoXiao [1 ,2 ]
Shi, Ming [3 ]
Wang, Qifei [1 ,2 ]
Hui, Jessica [4 ]
Shofaro, Joshua Hui [1 ,2 ]
Erkhembayar, Ryenchindorj [5 ]
Hui, Mizhou [1 ,2 ]
Gao, Chenzhe [1 ]
Gantumur, Munkh-Amgalan [1 ]
机构
[1] Northeast Agr Univ, Coll Life Sci, Harbin, Peoples R China
[2] Qingdao Agr Univ, Coll Vet Med, Qingdao, Peoples R China
[3] Harbin Inst Technol, Sch Life Sci & Technol, Harbin, Peoples R China
[4] Stanford Univ, Stanford Canc Inst, Ctr Canc Cell Therapy, Sch Med, Stanford, CA USA
[5] Mongolian Natl Univ Med Sci, Grad Sch, Dept Int Cyber Educ, Ulaanbaatar, Mongolia
关键词
hyaluronic acid; 35kDa hyaluronic acid fragment; B-HA; HA35; molecular weight; inflammation; inflammatory cells; reactive oxygen species; injection safety; MOLECULAR-MASS; 2; DEFICIENCY; EXPRESSION; PAIN; NEUTROPHIL; MICROGLIA; SIGLEC-9; PH-20; HAS2;
D O I
10.2147/JIR.S393495
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background: Hyaluronic acid (HA) and HA fragments interact with a variety of human body receptors and are involved in the regulation of various physiological functions and leukocyte trafficking in the body. Accordingly, the development of an injectable HA fragment with good tissue permeability, the identification of its indications, and molecular mechanisms are of great significance for its clinical application. The previous studies showed that the clinical effects of injectable 35kDa B-HA result from B-HA binding to multiple receptors in different cells, tissues, and organs. This study lays the foundation for further studies on the comprehensive clinical effects of injectable B-HA. Methods: We elaborated on the production process, bioactivity assay, efficacy analyses, and safety evaluation of an injectable novel HA fragment with an average molecular weight of 35 kDa (35 kDa B-HA), produced by recombinant human hyaluronidase PH20 digestion. Results: The results showed that 35 kDa B-HA induced human erythrocyte aggregation (rouleaux formation) and accelerated erythrocyte sedimentation rates through the CD44 receptor. B-HA application and injection treatment significantly promoted the removal of mononuclear cells from the site of inflammation and into the lymphatic circulation. At a low concentration, 35 kDa B-HA inhibited production of reactive oxygen species and tumor necrosis factor by neutrophils; at a higher concentration, 35 kDa B-HA promoted the migration of monocytes. Furthermore, 35 kDa B-HA significantly inhibited the migration of neutrophils with or without lipopolysaccharide treatment, suggesting that in local tissues, higher concentrations of 35 kDa B-HA have antiinflammatory effects. After 99mTc radiolabeled 35 kDa B-HA was intravenously injected into mice, it quickly entered into the spleen, liver, lungs, kidneys and other organs through the blood circulation. Conclusion: This study demonstrated that the HA fragment B-HA has good tissue permeability and antiinflammatory effects, laying a theoretical foundation for further clinical studies.
引用
收藏
页码:209 / 224
页数:16
相关论文
共 70 条
[21]   Leucocyte Trafficking via the Lymphatic Vasculature - Mechanisms and Consequences [J].
Jackson, David G. .
FRONTIERS IN IMMUNOLOGY, 2019, 10
[22]   Hyaluronan in the lymphatics: The key role of the hyaluronan receptor LYVE-1 in leucocyte trafficking [J].
Jackson, David G. .
MATRIX BIOLOGY, 2019, 78-79 :219-235
[23]   Hyaluronic Acid Biomaterials for Central Nervous System Regenerative Medicine [J].
Jensen, Gregory ;
Holloway, Julianne L. ;
Stabenfeldt, Sarah E. .
CELLS, 2020, 9 (09) :1-17
[24]   Pain regulation by non-neuronal cells and inflammation [J].
Ji, Ru-Rong ;
Chamessian, Alexander ;
Zhang, Yu-Qiu .
SCIENCE, 2016, 354 (6312) :572-577
[25]   A "GC-rich" method for mammalian gene expression: A dominant role of non-coding DNA GC content in regulation of mammalian gene expression [J].
Jia Qian ;
Wu HongTao ;
Zhou XingJun ;
Gao Jian ;
Zhao Wei ;
JouDi, Aziz ;
Wei JingShuang ;
Hou LiHua ;
Wu ShuYin ;
Zhang Ying ;
Dong XiangFeng ;
Huang YanMin ;
Jin WeiYuan ;
Zhu HongJie ;
Zhao XinHui ;
Huang ChunHua ;
Xing LiPing ;
Li LiWen ;
Ma Jun ;
Liu XiYan ;
Tao Ran ;
Ye ShuaiDong ;
Song YiGao ;
Song LingLing ;
Chen GuanPing ;
Du ChunLing ;
Zhang XueTing ;
Li Bo ;
Wang YanTao ;
Yang Wei ;
Rishton, Gilbert ;
Teng YuYang ;
Leng GouQing ;
Li LuanFeng ;
Liu WenXian ;
Cheng LiJun ;
Liang QiuBo ;
Li ZhengWu ;
Zhang XiuQin ;
Zuo YaJun ;
Chen Wei ;
Li HuiCheng ;
Hui, Matthew .
SCIENCE CHINA-LIFE SCIENCES, 2010, 53 (01) :94-100
[26]  
Jia X, 2021, Chinese and PCT Patent, Patent No. 2021102700130
[27]   A novel mechanism of erythrocyte capture from circulation in humans [J].
Kerfoot, Steven M. ;
McRae, Krista ;
Lam, Florence ;
McAvoy, Erin F. ;
Clark, Stephen ;
Brain, Michael ;
Lalor, Patricia F. ;
Adams, David H. ;
Kubes, Paul .
EXPERIMENTAL HEMATOLOGY, 2008, 36 (02) :111-118
[28]   Multifunctional Role of 35 Kilodalton Hyaluronan in Promoting Defense of the Intestinal Epithelium [J].
Kessler, Sean P. ;
Obery, Dana R. ;
Nickerson, Kourtney P. ;
Petrey, Aaron C. ;
McDonald, Christine ;
de la Motte, Carol A. .
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY, 2018, 66 (04) :273-287
[29]   Hyaluronan 35 kDa treatment protects mice from Citrobacter rodentium infection and induces epithelial tight junction protein ZO-1 in vivo [J].
Kim, Yeojung ;
Kessler, Sean P. ;
Obery, Dana R. ;
Homer, Craig R. ;
McDonald, Christine ;
de la Motte, Carol A. .
MATRIX BIOLOGY, 2017, 62 :28-39
[30]   Decreased erythrocyte binding of Siglec-9 increases neutrophil activation in sickle cell disease [J].
Kiser, Zachary M. ;
Lizcano, Anel ;
Nguyen, Julia ;
Becker, Greta L. ;
Belcher, John D. ;
Varki, Ajit P. ;
Vercellotti, Gregory M. .
BLOOD CELLS MOLECULES AND DISEASES, 2020, 81